शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
GAUDIUMIVFNSEGaudium IVF and Women Health LimitedHighNeutral
Announced Thu, 25 Jun, 2026 · 21:32 IST

Corrigendum to FY26 results, fixes minor clerical errors in FY25 comparatives

Revenue growth above 20%Profit growth above 25%Results restatedResults View source PDFExplain this filing

GAUDIUMIVF · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+2.0%Reaction day
₹108.63
prior close
—
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-0.3%+2.3% vs market

On the reaction day the stock moved 2.3 pts more than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs market
Reaction day
+2.0-0.3+2.3
Next day
+4.0+0.8+3.3
2d
+6.1+0.9+5.2
3d
+7.7+1.8+5.9
4d
+7.7+1.5+6.3
5d
+13.0+1.7+11.3
1w
+4.5-1.1+5.6
15d
+37.3+1.0+36.3
1m
+31.6+0.4+31.2
2m
+17.6+6.4+11.3
3m
+4.2+5.5-1.3
UpDownMarket · Nifty Microcap 250Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Gaudium IVF filed a corrigendum to fix minor typographical and regrouping errors in FY25 comparative figures appearing in its consolidated FY26 results. FY25 PAT was understated by 20.13 lakhs and is now corrected to 1,913.13 lakhs. Current year FY26 figures remain unchanged. Auditors confirmed no revision needed. For FY26, standalone revenue grew 21 percent to 7,158 lakhs and PAT rose 20 percent to 2,229 lakhs. Consolidated revenue jumped 48 percent to 10,436 lakhs with PAT up 28 percent to 2,449 lakhs. The company listed in February 2026 after a 90 crore IPO.

Likely market impact

No material impact on FY26 financials. Prior year comparatives corrected upward slightly. Strong FY26 revenue and profit growth signals positive momentum for shareholders.